Natravox
Brand Name: Natravox
Generic Name: Co-Amoxiclav
Active
Registration Number
DR-XY34776
Dosage Form
Powder For Suspension
Issuance Date
January 31, 2023
Expiry Date
August 11, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength228.5 mg per 5 mL
PackagingAmber Glass Bottle x 70mL (Box of 1's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
A
Application
Automatic Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Co-AmoxiclavActive
Monograph: co-amoxiclav